1. Clinical Overview
A high-potency, multi-strain probiotic formulation containing a defined quantity of live, freeze-dried lactic acid bacteria (primarily Lactobacillus species) and Bifidobacteria. It is designed to restore and maintain a healthy gut microbiota, which is crucial for digestive health, immune modulation, and metabolic functions. The freeze-drying process ensures long-term stability and viability of the bacteria until consumption.
| Onset | Duration | Bioavailability |
|---|---|---|
| Initial colonization and metabolic effects can begin within 24-48 hours, but significant clinical benefits for conditions like antibiotic-associated diarrhea may take 2-5 days of consistent use. | Effects are transient; the exogenous strains typically do not permanently colonize the gut. Sustained effects require continuous daily supplementation. Changes in gut microbiota composition may persist for 1-4 weeks after discontinuation, depending on diet and host factors. | Not applicable in the traditional pharmacokinetic sense. Viability (the percentage of live bacteria that survive gastric acid and bile to reach the intestines) is the critical metric, estimated at 20-40% for enteric-coated or acid-resistant formulations. |
2. Mechanism of Action
Exerts beneficial effects through multiple mechanisms: 1) Competitive Exclusion: Adheres to intestinal epithelium, competing with pathogens for binding sites and nutrients. 2) Production of Antimicrobial Substances: Lactic acid bacteria produce bacteriocins, organic acids (lactic acid, acetic acid), and hydrogen peroxide, creating an unfavorable environment for pathogenic bacteria. 3) Immunomodulation: Enhances innate and adaptive immunity by modulating cytokine profiles, increasing secretory IgA production, and interacting with gut-associated lymphoid tissue (GALT). 4) Strengthening Gut Barrier: Promotes mucin production and tight junction protein expression, reducing intestinal permeability ('leaky gut'). 5) Metabolic Functions: Ferment indigestible fibers to produce SCFAs, which serve as an energy source for colonocytes and have systemic anti-inflammatory effects.
3. Indications & Uses
- Prevention and treatment of Antibiotic-Associated Diarrhea (AAD)
- Management of Acute Infectious Diarrhea (as an adjunct to oral rehydration therapy)
- Symptomatic relief in Irritable Bowel Syndrome (IBS) - particularly for bloating, flatulence, and altered bowel habits
- Prevention of Necrotizing Enterocolitis (NEC) in preterm, low-birth-weight infants (specific strains)
4. Dosage & Administration
Adult Dosage: 112.5 Billion CFU (1 sachet/capsule) once or twice daily, as directed. For AAD prevention: Start with antibiotics and continue for 1-2 weeks after antibiotic course. For IBS: Once daily for at least 4 weeks to assess effect.
Administration: Take with or immediately after a meal (preferably breakfast or lunch) to buffer gastric acid. For sachets: Mix the powder in a small amount of cool or lukewarm water (<40°C), milk, or yogurt. Do not mix with hot liquids. Drink immediately. For capsules/tablets: Swallow whole with a glass of water. Do not crush or chew enteric-coated capsules. Maintain adequate hydration.
5. Side Effects
Common side effects may include:
- Mild abdominal bloating or distension during initial days of therapy
- Increased flatulence
- Mild abdominal cramps or rumbling
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Antibiotics (e.g., Ciprofloxacin, Amoxicillin) | Antibiotics may kill the probiotic bacteria, reducing efficacy. Conversely, probiotics may help prevent antibiotic-associated side effects. | Moderate |
| Immunosuppressants (e.g., Cyclosporine, Tacrolimus, high-dose corticosteroids) | Increased risk of probiotic-associated systemic infection in immunocompromised hosts. | Major |
| Antifungals (e.g., Fluconazole) | Unlikely to affect bacteria, but simultaneous use is common in clinical practice without noted interaction. | Minor |
| Sulfasalazine | Probiotics may enhance the metabolism of sulfasalazine to 5-ASA, potentially altering its local effect. Clinical significance unclear. | Moderate |
7. Patient Counselling
- DO take with or after a meal.
- DO store as per instructions (usually refrigerated, some are shelf-stable).
- DO complete the recommended course, especially with antibiotics.
- DO inform your doctor if you are severely immunocompromised before starting.
- DO NOT mix the powder in hot liquids.
- DO NOT take simultaneously with antibiotics; space intake by 2-3 hours.
- DO NOT use if the sachet/pack is bloated or damaged.
8. Toxicology & Storage
Overdose: Extremely unlikely to cause acute toxicity from overdose. Excessive intake may lead to pronounced gastrointestinal symptoms like severe bloating, gas, constipation, or diarrhea.
Storage: For most formulations: Store in a refrigerator (2°C to 8°C) to maintain potency and viability until the expiry date. Protect from moisture. Some newer shelf-stable brands may be stored below 25°C in a cool, dry place. ALWAYS CHECK THE SPECIFIC PRODUCT LABEL. Do not freeze unless instructed. Keep out of reach of children.